{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:30:20Z","timestamp":1787758220850,"version":"build-2784847793"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To evaluate the efficacy of 3-month administration of topical cyclosporin A (CsA) 0.05% on postoperative recurrence after pterygium surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      In this randomized clinical trial, 78 patients undergoing pterygium surgery (using the rotational conjunctival flap technique with mitomycin C [MMC]) were enrolled and randomly allocated into the control (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 39) and case (CsA) (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 39) groups in a single-blind method. The patients were examined on postoperative days 1, 3, and 7 and months 1, 3, and 6, and their best-corrected visual acuity, intraocular pressure, clinical inflammation, postoperative complications, and recurrence were compared.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The mean age of patients was 53.22 \u00b1 9.99 years; most (57.7%) of them were men. The two groups were not different in terms of demographics, pterygium size, or pterygium grade. The clinical inflammation at the first and third postoperative months was not different between the groups (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.108 and 0.780, respectively). No serious complications were detected; complication rates were not different between the groups (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.99). The recurrence rate was 5.1% in the case group and 7.7%% in the control group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.99).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The present study showed no priority for 3-month administration of CsA 0.05% drops on postoperative outcomes, including prevention of pterygium recurrence, complications, and inflammation after the rotational conjunctival autograft technique with MMC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/joco.joco_285_21","type":"journal-article","created":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T14:51:26Z","timestamp":1658847086000},"page":"208-215","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of Pterygium Recurrence with and Without Using Postsurgical Topical Cyclosporin a 0.05%"],"prefix":"10.4103","volume":"34","author":[{"given":"Yousef","family":"Alizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza Soltani","family":"Moghadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Dourandeesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Moravej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20240910","doi-asserted-by":"crossref","first-page":"e003787","DOI":"10.1136\/bmjopen-2013-003787","article-title":"Geographical prevalence and risk factors for pterygium: A systematic review and meta-analysis","volume":"3","author":"Liu","year":"2013","journal-title":"BMJ Open"},{"key":"R2-11-20240910","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.joco.2017.08.003","article-title":"Comparison of free conjunctival autograft versus amniotic membrane transplantation for pterygium surgery","volume":"29","author":"Akbari","year":"2017","journal-title":"J Curr Ophthalmol"},{"key":"R3-11-20240910","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/ICO.0000000000001744","article-title":"The evolving story of pterygium","volume":"37","author":"Young","year":"2018","journal-title":"Cornea"},{"key":"R4-11-20240910","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.4103\/ijo.IJO_3055_20","article-title":"Profile of complications in pterygium surgery - A retrospective analysis","volume":"69","author":"Kodavoor","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R5-11-20240910","doi-asserted-by":"crossref","first-page":"e0169675","DOI":"10.1371\/journal.pone.0169675","article-title":"Inhibition of pterygium fibroblast migration and outgrowth by bevacizumab and cyclosporine a involves down-regulation of matrix metalloproteinases-3 and -13","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS One"},{"key":"R6-11-20240910","first-page":"S5","article-title":"Pterygium: Epidemiology prevention and treatment","volume":"30","author":"Singh","year":"2017","journal-title":"Community Eye Health"},{"key":"R7-11-20240910","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1097\/ICO.0000000000002091","article-title":"Practice patterns in the management of primary pterygium: A survey study","volume":"38","author":"Graue-Hernandez","year":"2019","journal-title":"Cornea"},{"key":"R8-11-20240910","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.2147\/OPTH.S186543","article-title":"How to minimize pterygium recurrence rates: Clinical perspectives","volume":"12","author":"Nuzzi","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"R9-11-20240910","first-page":"522","article-title":"Clinical analysis of risk factors contributing to recurrence of pterygium after excision and graft surgery","volume":"8","author":"Ha","year":"2015","journal-title":"Int J Ophthalmol"},{"key":"R10-11-20240910","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/jrpp.JRPP_19_127","article-title":"Recurrence rate and clinical outcome of amniotic membrane transplantation combined with mitomycin C in pterygium surgery: Two-year follow-up","volume":"9","author":"Razmjoo","year":"2020","journal-title":"J Res Pharm Pract"},{"key":"R11-11-20240910","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/ICO.0000000000000853","article-title":"Risk factors for recurrence after pterygium surgery: An image analysis study","volume":"35","author":"Han","year":"2016","journal-title":"Cornea"},{"key":"R12-11-20240910","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/s41433-020-0786-3","article-title":"Pterygium: New insights","volume":"34","author":"Chu","year":"2020","journal-title":"Eye (Lond"},{"key":"R13-11-20240910","doi-asserted-by":"crossref","first-page":"528","DOI":"10.5935\/0004-2749.20190103","article-title":"Mechanisms and biomarker candidates in pterygium development","volume":"82","author":"Wanzeler","year":"2019","journal-title":"Arq Bras Oftalmol"},{"key":"R14-11-20240910","first-page":"400","article-title":"Topical tacrolimus as an adjunct to conventional therapy for stromal herpetic keratitis: A randomized clinical trial","volume":"14","author":"Akbari","year":"2019","journal-title":"J Ophthalmic Vis Res"},{"key":"R15-11-20240910","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/ICO.0000000000000477","article-title":"Cyclosporine a downregulates MMP-3 and MMP-13 expression in cultured pterygium fibroblasts","volume":"34","author":"Kim","year":"2015","journal-title":"Cornea"},{"key":"R16-11-20240910","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/bjophthalmol-2017-310288","article-title":"Comparison among adjuvant treatments for primary pterygium: A network meta-analysis","volume":"102","author":"Fonseca","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"R17-11-20240910","doi-asserted-by":"crossref","first-page":"372","DOI":"10.5935\/0004-2749.20190075","article-title":"Topical cyclosporine A 0.05% before and after surgery to prevent pterygium recurrence","volume":"82","author":"Meneghim","year":"2019","journal-title":"Arq Bras Oftalmol"},{"key":"R18-11-20240910","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.5301\/ejo.5000004","article-title":"Topical cyclosporine A administration after pterygium surgery","volume":"22","author":"\u00d6z\u00fclken","year":"2012","journal-title":"Eur J Ophthalmol"},{"key":"R19-11-20240910","first-page":"23","article-title":"Role of pre and postoperative topical cyclosporine (0.05%) on recurrence in recurrent and vascularised pterygium","volume":"16","author":"Dhar","year":"2017","journal-title":"J Dent Med Sci"},{"key":"R20-11-20240910","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0181-5512(08)74384-5","article-title":"Effectiveness of topical ciclosporin A treatment after excision of primary pterygium and limbal conjunctival autograft","volume":"31","author":"Aydin","year":"2008","journal-title":"J Fr Ophtalmol"},{"key":"R21-11-20240910","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1001\/archopht.1997.01100160405001","article-title":"Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision","volume":"115","author":"Tan","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"R22-11-20240910","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajo.2011.04.013","article-title":"Postoperative conjunctival inflammation after pterygium surgery with amniotic membrane transplantation versus conjunctival autograft","volume":"152","author":"Kheirkhah","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"R23-11-20240910","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0161-6420(97)30197-3","article-title":"Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision","volume":"104","author":"Prabhasawat","year":"1997","journal-title":"Ophthalmology"},{"key":"R24-11-20240910","first-page":"73","article-title":"Comparative study on the use of conjunctival autograft with or without mitomycin-C in pterygium surgery","volume":"39","author":"Agahan","year":"2014","journal-title":"Philipp J Ophthalmol"},{"key":"R25-11-20240910","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3341\/kjo.2015.29.6.375","article-title":"A comparative study of topical mitomycin C, cyclosporine, and bevacizumab after primary pterygium surgery","volume":"29","author":"Hwang","year":"2015","journal-title":"Korean J Ophthalmol"},{"key":"R26-11-20240910","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000151740","article-title":"Topical cyclosporine A in the prevention of pterygium recurrence","volume":"222","author":"Yalcin Tok","year":"2008","journal-title":"Ophthalmologica"},{"key":"R27-11-20240910","first-page":"188","article-title":"Role of topical cyclosporine in prevention of pterygium recurrence, after primary excision","volume":"35","author":"Ahmed","year":"2019","journal-title":"Pakistan J Ophthalmol"},{"key":"R28-11-20240910","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/ICO.0000000000001542","article-title":"Adjuvant use of cyclosporine a in the treatment of primary pterygium: A systematic review and meta-analysis","volume":"37","author":"Zhang","year":"2018","journal-title":"Cornea"},{"key":"R29-11-20240910","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4314\/ahs.v14i1.11","article-title":"Young patient's age determines pterygium recurrence after surgery","volume":"14","author":"Anguria","year":"2014","journal-title":"Afr Health Sci"},{"key":"R30-11-20240910","first-page":"120","article-title":"Pterygium recurrence related to its size and corneal involvement","volume":"23","author":"Mahar","year":"2013","journal-title":"J Coll Physicians Surg Pak"},{"key":"R31-11-20240910","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jtos.2014.01.001","article-title":"Surgical management of pterygium","volume":"12","author":"Janson","year":"2014","journal-title":"Ocul Surf"}],"container-title":["Journal of Current Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/joco.joco_285_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:06:57Z","timestamp":1787756817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/joco.joco_285_21"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/joco.joco_285_21","relation":{},"ISSN":["2452-2325"],"issn-type":[{"value":"2452-2325","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}